Regular Article
P-Glycoprotein Deficiency in a Subpopulation of CF-1 Mice Enhances Avermectin-Induced Neurotoxicity

https://doi.org/10.1006/taap.1996.8086Get rights and content

Abstract

A subpopulation of CF-1 mice is unusual in its sensitivity to the avermectins, abamectin and ivermectin, with neurotoxicity occurring at 100-fold lower doses than in other species and mouse strains. We have shown that the sensitive CF-1 mice are deficient in P-glycoprotein in the intestinal epithelium and brain capillary endothelium, tissues forming the principle barriers for penetration into the systemic circulation and central nervous system, respectively. Consistent with the role of P-glycoprotein as a barrier to tissue entry, the plasma and tissue levels of radiolabeled ivermectin in the sensitive mice were markedly higher than in the insensitive mice, particularly in brain, the target organ for toxicity. Insensitive CF-1 and CD-1 mice showed abundant levels of P-glycoprotein in these tissues and tolerated doses of abamectin at least 50-fold the minimum toxic dose in the sensitive subgroup. In view of these findings in CF-1 mice with both abamectin and the structural analog ivermectin, which is used extensively in the treatment of human filariasis with no evidence of neurotoxicity, it is likely that this protein, found in human brain endothelium, is highly conserved in the human population.

References (28)

  • W. Beck

    Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells

    (1991)
  • J. Chin et al.

    Structure and expression of the humanMDR

    Mol. Cell. Biol.

    (1989)
  • S. Chiu et al.

    Metabolism and tissue residues

    Ivermectin and Abamectin

    (1989)
  • Cited by (192)

    • Neurovascular development

      2023, Encyclopedia of Child and Adolescent Health, First Edition
    • A perspective on the discovery of selected compounds with anthelmintic activity against the barber's pole worm—Where to from here?

      2020, Advances in Parasitology
      Citation Excerpt :

      By targeting the ion channels, macrocyclic lactones increase membrane permeability to chloride ions, leading to reduced pharyngeal pumping, paralysis of body muscles, and having adverse effects on the uterus (Geary et al., 1993; Gill et al., 1991; Sargison, 2012; Sutherland and Campbell, 1990; Yates et al., 2003). Macrocyclic lactones exhibit a rather selective toxicity in nematodes, presumably due to cell-membrane efflux pumps, in particular the P-glycoproteins (Broeks et al., 1995), which can exclude macrocyclic lactone drugs from distributing into the central nervous system (Kerboeuf et al., 2003; Lankas et al., 1997; McKellar and Jackson, 2004). There are studies showing that P-glycoprotein inhibitors can improve the efficacy of macrocyclic lactones through oral absorption, because P-glycoproteins are also present in the gut (Lifschitz et al., 2002; McKellar and Jackson, 2004).

    • Anthelmintic drugs used in equine species

      2018, Veterinary Parasitology
    • Impact of endotoxin on the expression of drug transporters in the placenta of HIV-1 transgenic (HIV-Tg) rats

      2017, European Journal of Pharmaceutical Sciences
      Citation Excerpt :

      It has been reported that several HIV viral proteins including gp120, tat and nef are capable of activating lymphocytes and macrophages, causing the release of pro-inflammatory cytokines IL-6 and TNF-α (Lee et al., 2003; Swingler et al., 2003; Appay and Sauce, 2008; Yim et al., 2009; Mogensen et al., 2010). Altered expression of placental drug transporters has been linked to higher transplacental passage, as well as drug-induced birth defects in rodents (Lankas et al., 1997; Smit et al., 1999; Choo et al., 2000; Pavek et al., 2003). Given the high incidence of subclinical endotoxemia in HIV infected individuals, our objective was to examine the impact of low-dose endotoxin on the expression of placental drug transporters in a pregnant HIV-Tg rat model.

    View all citing articles on Scopus

    W. C. Campbell, Ed.

    View full text